Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04098991 · ClinicalTrials.gov registry record
Improving White Matter Integrity With Thyroid Hormone
A clinical trial, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 5
- Enrollment target
NCT04098991: Completed study, sponsored by University of Illinois at Chicago.
NCT04098991 is a clinical trial that has completed, run by University of Illinois at Chicago. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04098991 has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Animal studies have shown that thyroid hormone can improve white matter integrity after damage to myelin, which insulates and protects nerves. It is currently unknown whether this type of repair can occur in humans. The purpose of the proposed study is to examine the impact of thyroid hormone on white matter integrity in humans using two complementary, state-of-the-art neuroimaging techniques: high angular diffusion imaging and multicomponent relaxometry.
Primary Outcome
Change in baseline white matter track integrity at 3 months and 6 months
Interventions
- DRUG Levothyroxine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-11-08 |
| Est. Completion | 2019-11-08 |
What the finished NCT04098991 record still lists
NCT04098991 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Levothyroxine is the first listed.
NCT04098991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04098991 about?
NCT04098991 is a clinical study titled "Improving White Matter Integrity With Thyroid Hormone". Animal studies have shown that thyroid hormone can improve white matter integrity after damage to myelin, which insulates and protects nerves. It is currently unknown whether this type of repair can occur in humans. The purpose of the proposed study is to examine the impact of thyroid hormone on whi...
What is the current status of trial NCT04098991?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2017-11-08. Estimated completion is 2019-11-08.
What interventions are being tested in trial NCT04098991?
The interventions under investigation include: Levothyroxine (DRUG).
Who is sponsoring clinical trial NCT04098991?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI